Table 1.
Primary Diagnosis at Visit | gPop | ID | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
All | Women | Men | Women vs. Men | All | Women | Men | Women vs. Men | ||||
n (%) | n (%) | n (%) | RR b (95% CI) | n (%) | RR a (95% CI) | n (%) | RR a (95% CI) | n (%) | RR a (95% CI) | RR b (95% CI) | |
Any | 252 (3) | 119 (3) | 133 (3) | 0.93 (0.73–1.19) | 152 (2) | 0.60 (0.49–0.74) | 77 (2) | 0.65 (0.49–0.96) | 75 (2) | 0.56 (0.43–0.75) | 0.81 (0.59–1.11) |
Bronchitis, not specified as acute or chronic | 15 (0) | 7 (0) | 8 (0) | 0.95 (0.35–2.63) | 14 (0) | 0.93 (0.45–1.93) | 6 (0) | 0.86 (0.29–2.55) | 8 (0) | 1.00 (0.38–2.66) | 1.11 (0.39–3.20) |
Simple and mucopurulent chronic bronchitis | 13 (0) | 5 (0) | 8 (0) | 1.34 (0.44–4.08) | <5 | <5 | <5 | ||||
Unspecified chronic bronchitis | 10 (0) | 8 (0) | <5 | 6 (0) | 0.60 (0.22–1.65) | 5 (0) | 0.63 (0.21–1.91) | <5 | |||
Emphysema | 10 (0) | <5 | 6 (0) | <5 | <5 | <5 | |||||
Other chronic obstructive pulmonary disease (COPD) | 137 (2) | 60 (2) | 77 (2) | 1.07 (0.77–1.50) | 64 (1) | 0.47 (0.35–0.63) | 26 (1) | 0.43 (0.27–0.69) | 38 (1) | 0.49 (0.34–0.73) | 1.22 (0.74–2.00) |
Asthma | 105 (1) | 51 (1) | 54 (1) | 0.88 (0.60–1.29) | 85 (1) | 0.81 (0.61–1.08) | 49 (1) | 0.96 (0.65–1.42) | 36 (1) | 0.67 (0.44–1.01) | 0.61 (0.40–0.94) |
Status asthmaticus | 10 (0) | <5 | 6 (0) | 6 (0) | 0.60 (0.22–1.65) | <5 | <5 | ||||
Bronchiectasis | 9 (0) | 6 (0) | <5 | <5 | <5 | <5 |
a: ID vs. gPop; b: Within the ID cohort. Note: Relative risks (RRs) are given with 95% confidence intervals (CIs). RRs are presented only if both groups to be compared are comprised of at least five individuals.